Article Details

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with ...

Retrieved on: 2020-12-30 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with .... View article details on hiswai:

Excerpt

LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up